GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Other Operating Expense

Quest PharmaTech (TSXV:QPT) Other Operating Expense : C$0.00 Mil (TTM As of Oct. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Other Operating Expense?

Quest PharmaTech's Other Operating Expense for the three months ended in Oct. 2023 was C$0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Oct. 2023 was C$0.00 Mil.

Quest PharmaTech's quarterly Other Operating Expense declined from Apr. 2023 (C$0.00 Mil) to Jul. 2023 (C$0.00 Mil) but then stayed the same from Jul. 2023 (C$0.00 Mil) to Oct. 2023 (C$0.00 Mil).

Quest PharmaTech's annual Other Operating Expense increased from Jan. 2021 (C$-0.00 Mil) to Jan. 2022 (C$0.00 Mil) but then declined from Jan. 2022 (C$0.00 Mil) to Jan. 2023 (C$-0.00 Mil).


Quest PharmaTech Other Operating Expense Historical Data

The historical data trend for Quest PharmaTech's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Other Operating Expense Chart

Quest PharmaTech Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quest PharmaTech Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Quest PharmaTech Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest PharmaTech Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech (TSXV:QPT) Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines